Model 305 Pulse Oximeter

...e laboratory and a worldwide leader in innovative ...n extensive test menu of highly complex and unique... Owned by the University of Utah, ARUP Laboratorie...university teaching hospitals and children's hospi...

Medicine Products:

C3 Proactivator C3 C-1-Esterase Inhibitor Panel C12

(Date:11/9/2009)...re-USNewswire/ -- For the third consecutive year, ...lected the most preferred hospital for cancer care...he National Research Corporation. ,, (Logo: ...NOSLOGO ) ,, The annual survey was conducted t...08 and August 2009. Survey respondents were the pr...

(Date:11/9/2009)...ire/ -- Phoenix House , the nation,s leading ...evention program, announced today its appointment ...nally recognized leader in substance abuse treatme...ive January 1, 2010. ,, "Dr. Deni Carise is a...research and her work has resulted in a significan...

(Date:11/9/2009)... At a time when the 250,000+ eligi...concerned about finding affordable health insuranc... 2010. ,, The Today,s Options® Preferred P... provides a cost-effective and comprehensive alter...nt plan. People with Medicare can choose to sign ...

(Date:11/9/2009)...wire/ -- , , WHAT: All PETCO stores nationw...orkshop facilitated by specially trained in-store ...ber 14 at 2 p.m. During the 30-minute, ...itional needs of, their dogs and cats... good pet nutrition, receive an assessment o...

(Date:11/9/2009)...cember issue of European Urology , the official j...tures an article entitled ,Are Infertile Men Less ... Case-Control Survey, by Dr. Andrea Salonia et al.... associated with a number of medical comorbidities...arlson Comorbidity Index. , Dr. Andrea Salonia f...

Breaking Medicine News(10 mins):Health News:Karmanos Cancer Center Most Preferred Hospital for Cancer Care in Southeast Michigan, Third Consecutive Year 2 Health News:Phoenix House Appoints Dr. Deni Carise as Chief Clinical Officer - Internationally Recognized Leader in Substance Abuse Treatment and Research 2 Health News:Phoenix House Appoints Dr. Deni Carise as Chief Clinical Officer - Internationally Recognized Leader in Substance Abuse Treatment and Research 3 Health News:Maine Residents With Medicare Searching for Affordable and Innovative Insurance Have Competitive Medicare Advantage Option 2 Health News:European Urology: Male factor infertility associated with comorbidities 2

[0] Karmanos Cancer Center Most Preferred Hospital for Cancer Care in Southeast Michigan, Third Consecutive Year [0] Phoenix House Appoints Dr. Deni Carise as Chief Clinical Officer - Internationally Recognized Leader in Substance Abuse Treatment and Research [0] Maine Residents With Medicare Searching for Affordable and Innovative Insurance Have Competitive Medicare Advantage Option [0] PETCO Stores Nationwide Host Pet Nutrition Workshops [0] European Urology: Male factor infertility associated with comorbidities

...ction to be Favored, ADDIS ABABA, Ethiopia, Jan. ...eric drug manufacturing subsidiary of,Rx for Afric...fit greatly,from powerful new incentives for Ethio...port of our,burgeoning industry. The health of Eth...

...nues Benefit from Strong International Performance...Sales, GLENWOOD, Ill., Jan. 31 Landauer, Inc. (N...ironmental radiation,monitoring, today reported re...ion on higher international revenues in severa...

...) survey reveals Boomers feel young, but often ign...fitness expert Denise Austin to launch .... 31 Baby boomers are living,longer and leading m...Holdings, Inc. (NYSE: ENR ), nearly two-thirds,(6...

... Jan. 31, 2008 The Procter &,Gamble Company (NYSE... to,$21.6 billion for the quarter. Sales were up b...on key product initiatives and double-digit organi...e increased 17 percent to $0.98 per share, above t...

...easoned Employees through Long Term Healthcare Edu...mes, older,experienced employees are the ones comp...leave of their own accord. Or they may start takin...Director of Business Development for LTC Financial...

...ith rheumatoid arthritis (RA), an inflammatory aut...from cardiovascular disease (CVD). One explanatio...flammation promotes atherosclerosis. A marker of ...tory diseasesCrohns, for exampledo not carry the s...

Rx for Africa, Inc. to Benefit from New Ethiopian Government Policy on Pharma Industry Landauer, Inc. Reports Strong Fiscal 2008 First Quarter Results Boomers: Feeling Young or Fooling Themselves?P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company Protecting Productivity at the Worksite in Challenging Times The HLA-DRB1 gene and premature death in rheumatoid arthritis

(Date:11/9/2009)... PAREXEL International Corporation (Nasdaq: PRXL ...vider, today announced that it has enhanced its ca... development through an alliance with Mortara Inst...lectrocardiogram (ECG) devices and related technol...,s Surveyor Telemetry Central System to supplement...

(Date:11/8/2009)...re Reform Bill ,, Critical legislation would ...icans ,, BOISE, Idaho, Nov. 7 /PRNewswire-US...esentatives passed critical health care reform leg...s and end discrimination by insurance companies th...health coverage. ,, The Affordable Health Car...

(Date:11/6/2009)...Call/ -- SCOLR Pharma, Inc. (Amex: DDD ) today re...nths ended September 30, 2009. ,, Stephen J. ...e continue to advance discussions related to licen...tential partners have committed significant resour...hey evaluate the potential commercial and/or licen...

Breaking Medicine Technology:PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 2 PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 3 PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 4 PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 5 AARP Idaho Key Vote News Alert 2 AARP Idaho Key Vote News Alert 3 SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 2 SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 3 SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 4 SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 5 SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 6 SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 7 SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 8 SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 9 Printing New Organs 3A Foundation Funds Medical Technology That Replicates Human Tissue 12545 1 Printing New Organs 3A Foundation Funds Medical Technology That Replicates Human Tissue 12545 2 NIAHC Premiers Its Natural Health Care and Balanced Living Website 48305 1 NIAHC Premiers Its Natural Health Care and Balanced Living Website 48305 2 Twelve Year Old Girl With Facial Paralysis Is Smiling Again After Cutting Edge Facial Plastic Surgery 48300 1 Twelve Year Old Girl With Facial Paralysis Is Smiling Again After Cutting Edge Facial Plastic Surgery 48300 2 Twelve Year Old Girl With Facial Paralysis Is Smiling Again After Cutting Edge Facial Plastic Surgery 48300 3

[0] PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument [0] AARP Idaho Key Vote News Alert [0] SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results

Products	Model 305 Pulse Oximeter
Company	Mediaid Inc.
Item	Model 305 Pulse Oximeter
Features	Intended for spot-check pulse oximetry Fits into lab coat pocket NiCad rechargeable battery for easy portability and 12 hours of continual use Bright LED displays for oxygen saturation and pulse rate Rugged, water-resistant case withstands shock and vibration
Description	The Model 305 is a hand-held, portable, lightweight oximeter designed for spot checking. It has a NiCad rechargeable battery.
Info	Mediaid Inc. Customer Service: (310) 793-8844 Web site: http://www.mediaidinc.com/